Viewing nowOmepran 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Wonkwang Pharmaceutical Co., Ltd.

MFDS item code 202000226 · Approved 2020.01.15 · Insurance code 662600850
Treatment and prevention of reflux disease and Zollinger-Ellison syndrome, ulcers and Helicobacter pylori infection, and gastrointestinal disorders caused by anti-inflammatory analgesics
This drug is used for the treatment of gastroesophageal reflux disease, particularly for erosive esophagitis and for long-term maintenance therapy to prevent recurrence of esophagitis. It is also administered in combination with antibiotics for the treatment of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It briefly alleviates gastrointestinal pain or discomfort associated with the use of nonsteroidal anti-inflammatory drugs and is effective for the treatment and prevention of gastric and duodenal ulcers with long-term use. It is also used for maintenance therapy in the treatment of Zollinger-Ellison syndrome and for the prevention of rebleeding in gastric and duodenal ulcers. Actively used for the treatment and prevention of various gastrointestinal diseases, it improves the patient's symptoms.
This medicine should be swallowed with a liquid such as water. Do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have improved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective and selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring ongoing administration of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dosage should be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration. 4. Renal impairment No dosage adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal impairment. 5. Hepatic impairment No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Older adults No dosage adjustment is necessary.
2. Adolescents 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have improved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 3. Children under 12 years There is no experience with administration of this medicine to children under 12 years.
This medicine should not be administered to certain patients. Those allergic to this drug or its components, or with a history of hypersensitivity reactions to benzimidazole derivatives, should not use it. It is also safer not to administer it to individuals taking certain antibiotics or antivirals, nursing women, or patients with a history of myocardial infarction. Various side effects may occur when taking this drug. Gastrointestinal symptoms such as headache, dizziness, abdominal pain, diarrhea, nausea, and vomiting are frequently reported, and rare cases of blood abnormalities, allergic reactions, skin rash, and hepatic dysfunction may occur. Additionally, long-term use may increase the risk of hypomagnesemia or fractures, so caution is advised. It is important to check for abnormalities through regular examinations if this drug is used for a long period. Patients taking it for more than a year should consistently monitor magnesium levels and bone density. This drug may interact with other medications, so consulting a doctor or pharmacist about currently taking medications is essential. Caution is particularly needed when used with anticoagulants, anticonvulsants, certain antibiotics, and antivirals. Pregnant or nursing women should consult a healthcare professional before using this drug, and it is recommended to avoid use if possible. In case of overdose, there is no specific antidote, so it is necessary to receive appropriate treatment based on symptoms. Lastly, this drug should be kept out of the reach of children and not transferred to other containers for safety.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distention, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, influenza-like illness, general edema, leg edema, malaise, pain, stiffness, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, taste loss, taste distortions, abnormal urination, albuminuria, cystitis, dysuria, fungal infections, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric gland polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This drug must be stored in a tightly closed container to protect it from air and moisture. It is also safe to keep the drug at room temperature, specifically between 1 degree and 30 degrees Celsius, avoiding extremes of heat or cold.
Pink rectangular film-coated tablet
Alu-Alu - 28 tablets/box [28 tablets (14 tablets/Alu-Alu * 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Wonkwang Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.